Log in to save to my catalogue

Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2616609683

Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

About this item

Full title

Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

Publisher

New York: Springer US

Journal title

Molecular neurobiology, 2022-02, Vol.59 (2), p.1262-1272

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Resistance to temozolomide (TMZ) chemotherapy is the main reason for treatment failure in patients with glioblastoma (GBM). In the present study, we investigated biochanin A (BCA) a potent sensitizer of TMZ in GBM. We observed that BCA significantly enhanced cell sensitivity to TMZ in vitro and in vivo. Mechanistically, the specific chemosensitizin...

Alternative Titles

Full title

Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2616609683

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2616609683

Other Identifiers

ISSN

0893-7648

E-ISSN

1559-1182

DOI

10.1007/s12035-021-02674-6

How to access this item